Sustained elevation of Epstein–Barr virus antibody levels preceding clinical onset of nasopharyngeal carcinoma

We have monitored Epstein–Barr virus (EBV) IgA antibody levels of 39 nasopharyngeal carcinoma (NPC) cases for up to 15 years before clinical onset of NPC, and assessed preclinical serologic status of another 68 cases. Our results identify a serologic window preceding diagnosis when antibody levels a...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Ji, M F, Wang, D K, Yu, Y L, Guo, Y Q, Liang, J S, Cheng, W M, Zong, Y S, Chan, K H, Ng, S P, Wei, W I, Chua, D T T, Sham, J S T, Ng, M H
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Nature Publishing Group 2007
Konular:
Molecular Diagnostics
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC2360049/
https://ncbi.nlm.nih.gov/pubmed/17285127
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6603609
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller